The use of ceruloplasmin drugs for correction of anemia and intoxication in patients with chronic kidney disease

Ya.A. Dombrovskyi, M.D. Ivanova

Abstract


Anemia - reduction of the total number of erythrocytes and / or hemoglobin in the blood volume unit. Ceruloplasmin drugs are using for stimulation of hematopoiesis, detoxication (reduction of intoxication), immune reconstitution. The topic of this article is an analysis of pharmacodynamics, efficacy, safety and expediency of using ceruloplasmin drugs for correction of anemia in patients with chronic kidney disease.


Keywords


Anemia; chronic kidney disease; ceruloplasmin

References


Клінічні практичні настанови KDIGO з анемії при ХХН // Почки. — 2013. — № 1. — С. 71-76.

К патогенезу анемии при хронической почечной недостаточности (ХПН) у больных, находящихся на гемодиализе, и ее коррекция церулоплазмином: Автореф. дис... к.м.н. Солодовниковой О.А. — Челябинск, 2004.

Ващенко В.И., Ващенко Т.Н. Церулоплазмин: от метаболита до лекарственного средства // Психофармакология и биологическая наркология. — 2006. — № 6. — С. 1254-1269.

Kidney International Supplements. — 2012. — 2. — 288-291; doi:10.1038/kisup.2012.33.

http://www.kdigo.org/clinical_practice_guidelines/pdf/KDIGO-Anemia %20GL.pdf

Kuwahara M., Hasumi S., Mandai S., Tanaka T., Shikuma S., Akita W., Mori Y., Sasaki S. Effects of three kinds of erythropoiesis-stimulating agents on renal anemia in Japanese non-dialysis chronic kidney disease patients // Clin. Exp. Nephrol. — 2013 Dec 7.

Chung M., Chan J.A., Moorthy D., Hadar N., Ratichek S.J., Concannon T.W., Lau J. Biomarkers for Assessing and Managing Iron Deficiency Anemia in Late-Stage Chronic Kidney Disease: Future Research Needs: Identification of Future Research Needs From Comparative Effectiveness Review No. 83 Internet. Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Jan. ReportNo.: 13-EHC038-EF.

Zadrazil J., Horak P. Pathophysiology of anemia in chronic kidney diseases. A review. Biomed Pap Med FacUnivPalacky Olomouc Czech Repub. — 2014 Jan 3; doi: 10.5507/bp.2013.093.

Mohammadpour A.H., Nazemian F., Khaiat M.H., Tafaghodi M., Salari P., Charkazi S., Naghibi M., Shamsara J. Evaluation of the effect of pentoxifylline on erythropoietin-resistant anemia in hemodialysis patients // Saudi J. Kidney Dis. Transpl. — 2014 Jan-Feb. — 25 (1). — 73-8.

Fiore D.C., Fox C.L. Urology and nephrology update: anemia of chronic kidney disease. FP Essent. — 2014 Jan. — 416. — 22-5.

Suzuki Y., Yoshida K., Aburakawa Y., Kuroda K., Kimura T., Terada T., Kono S., Miyajima H., Yahara O. Effectiveness of oral iron chelator treatment with deferasirox in an aceruloplasminemia patient with a novelceruloplasmin gene mutation // Intern. Med. — 2013. — 52 (13). — 1527-30.

Malyszko J. New renal anemia drugs: is there really anything new on the horizon? // Expert Opin. Emerg. Drugs. — 2013 Dec 18.

Eid C., Hemadi M., Ha-Duong N.T., El Hage Chahine J.M. Iron uptake and transfer from ceruloplasmin to transferrin // Biochim Biophys Acta. — 2014 Jan 11; pii: S0304-4165(14)00013-0. doi: 10.1016/j.

http://en.wikipedia.org/wiki/Ceruloplasmin

http://www.xumuk.ru/farmacevt/1238.html

http://www.likar.info/lekarstva/Ceruloplazmin/

http://www.biofarma.ua/ru/catalogue/abc/ %D0 %91/biotserulin

Burtis C., Ashwood E., Bruns D. Tietz textbook of clinical chemistry and molecular diagnostics // Elsevir Inc. — 2006. — 2412 p.

Nathan E., Hellman and Jonathan D. Gitlin. Ceruloplasmin metabolism and function // Annual Review of Nutrition. — Vol. 22. — 439-458. DOI: 10.1146/annurev.nutr.22.012502.114457

Mittal B., Doroudchi M.M., Jeong S.Y., Patel B.N., David S. Expression of a membrane-bound form of the ferroxidaseceruloplasmin by leptomeningeal cells // Glia. — 2003 Mar. — 41 (4). — 337-46.

Jocelyn E. Wiggins, Meera Goyal, Bryan L. Wharram, Roger C. Wiggins. Antioxidant Ceruloplasmin Is Expressed by Glomerular Parietal Epithelial Cells and Secreted into Urine in Association with Glomerular Aging and High-Calorie Diet. — Published online before print April 5, 2006, doi:10.1681/ASN.2005111239JASN May 2006 vol. 17 no. 5 1382-1387

Ceruloplasmin impairs endothelium-dependent relaxation of rabbit aorta / M. Cappelli-Bigazzi et al. // Am. J. Physiol. — 1997. — Vol. 273. — P. H2843-H2849.

Alper B.S. Using ferritin levels to determine iron-deficiency anemia in pregnancy / B.S. Alper, R. Kimber, A.K. Reddy // J. Fam. Pract. — 2000. — Vol. 49, № 9. — P. 829-832.

Новые возможности профилактики и коррекции послеоперативных гнойно-септических осложнений и полиорганной недостаточности в онкохирургии / Н.В. Эделева и др. // Анестезиология и реаниматология. — 1997. — № 3. — С. 36-41.

Шиффман Ф.Дж. Патофизиология крови / Дж.Ф. Шиффман: Пер. с англ. — М.; СПб.: БИНОМ: Невский диалект, 2000. — 448 с.

Щербакова В.В. Железодефицитная анемия беременных / В.В. Щербакова, И. Тихая // Международный медицинский журнал. — 2000. — № 3. — С. 73-75.

Протопопова Н.В. Клинико-патологическое обоснование профилактики ЖДА в группах высокого риска: Автореф. дис... д-ра мед. наук / Н.В. Протопопова. — Омск, 1982. — 34 с.

Сахибов Я.Д. Продолжительность жизни эритроцитов при железодефицитных состояниях // Тер. архив. — 1981. — Т. 53, № 9. — С. 30-33.

Blood letting in high-ferritin type 2 diabetes: effects on insulin sensitivity and f3-cell function / J.M. Fernandez-Real et al. // Diabetes. — 2002. — Vol. 51. — P. 1000-1004.

Defective antioxidants mechanisms via changes in serum ceruloplasmin and total iron binding capacity of serum in women with pre-eclampsia / N. Vitoratos et al. // Eur. J. Obstet. Gynecol. — 1999. — Vol. 84. — P. 63-67.

Arimory S. Treatment on aplastic anemia, with special reference to ceruloplasmin // Jap. J. Clin. Exp. Med. —1966. — Vol. 43, № 11. — P. 1897-1898.

Shimizu M. Clinical results on the use of human ceruloplasmin in aplastic anemia // Transfusion. —1979. — Vol. 19, № 8. — P. 742-748.

Katsunuma H. et al. Clinical experience with ceruloplasmin on aplastic anemia // Jap. J. Clin. Med. — 1961. — Vol. 19, № 3. — P. 424-428.

Бердинских Н.К. // Новости медицины и фармации. — 2006. — № 15-16.




DOI: https://doi.org/10.22141/2307-1257.0.1.07.2014.76550

Refbacks

  • There are currently no refbacks.


Copyright (c) 2016 KIDNEYS

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© "Publishing House "Zaslavsky", 1997-2017

 

 Яндекс.МетрикаSeo анализ сайта Рейтинг@Mail.ru